MD5Y - Metoda de inlaturare a dislocarii cristalinului artificial - Google Patents

Metoda de inlaturare a dislocarii cristalinului artificial Download PDF

Info

Publication number
MD5Y
MD5Y MDS20080014A MDS20080014A MD5Y MD 5 Y MD5 Y MD 5Y MD S20080014 A MDS20080014 A MD S20080014A MD S20080014 A MDS20080014 A MD S20080014A MD 5 Y MD5 Y MD 5Y
Authority
MD
Moldova
Prior art keywords
dislocation
eliminating
lens
intraocular lens
solution
Prior art date
Application number
MDS20080014A
Other languages
English (en)
Inventor
Ion Jeru
Original Assignee
Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova filed Critical Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority to MDS20080014A priority Critical patent/MD5Z/ro
Publication of MD5Y publication Critical patent/MD5Y/ro
Publication of MD5Z publication Critical patent/MD5Z/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Inventia se refera la oftalmologie, in special la o metoda de inlaturare a dislocarii cristalinului artificial. Esenta inventiei consta in aceea caconcomitent se administreaza subconjunctival 0,3 ml de solutie de Mezaton 1%, intravenos 2,0 ml deFurosemid si per os 0,25 mg de Diacarb, apoi peste 30 min in conditii obscure la iluminarea directa a corneei cu oftalmoscopul se aplica o presiune cu microspatula in regiunea limbului, si anume pe meridianul dislocarii ansei cristalinului pana la repozitia ei sub iris, dupa care se administreaza subconjunctival o picatura de solutie de Pilocarpina 1%.
MDS20080014A 2008-07-17 2008-07-17 Metodă de înlăturare a dislocării cristalinului artificial MD5Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20080014A MD5Z (ro) 2008-07-17 2008-07-17 Metodă de înlăturare a dislocării cristalinului artificial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20080014A MD5Z (ro) 2008-07-17 2008-07-17 Metodă de înlăturare a dislocării cristalinului artificial

Publications (2)

Publication Number Publication Date
MD5Y true MD5Y (ro) 2009-02-28
MD5Z MD5Z (ro) 2009-09-30

Family

ID=45094332

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20080014A MD5Z (ro) 2008-07-17 2008-07-17 Metodă de înlăturare a dislocării cristalinului artificial

Country Status (1)

Country Link
MD (1) MD5Z (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (ro) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de determinare a markerilor hepatitei virale B în sângele donatorului
  • 2008
    • 2008-07-17 MD MDS20080014A patent/MD5Z/ro not_active IP Right Cessation

Also Published As

Publication number Publication date
MD5Z (ro) 2009-09-30

Similar Documents

Publication Publication Date Title
EA201000441A1 (ru) Водные офтальмологические препараты
CO6351718A2 (es) Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular
EA201071413A1 (ru) Способ и композиция для лечения повышения внутриглазного давления и глаукомы
JP2006514696A (ja) 眼球の症状の予防及び治療のための眼科用製剤
WO2009146151A3 (en) Corneal onlay devices and methods
WO2010085696A3 (en) Sustained released delivery of one or more agents
RU2017139870A (ru) Новые агонисты npr-b
Ritch Natural compounds: evidence for a protective role in eye disease
MX2018001918A (es) Aplicación cuantitativa periorbital de farmacos oftalmologicos.
Shen et al. Enhanced topical corticosteroids delivery to the eye: a trade-off in strategy choice
US20150164635A1 (en) Method of Reducing the Occurrence of Macular and Neuroretinal Degenerations by Alleviating Age Related Retinal Stresses as a Contributing Factor in a Mammalian Eye
CL2012001737A1 (es) Uso de una composicion topica oftalmica seleccionada del grupo formado por colirios, pomadas y unguentos que contienen un peptido seleccionado entre somatostatina o un análogo de somatostatina, para el tratamiento y/o prevencion de enfermedades especificas del segmento posterior del ojo.
MX2016006334A (es) Metodos de tratamiento de enfermedades oculares con un implante para la administracion sostenida de farmacos.
MD5Y (ro) Metoda de inlaturare a dislocarii cristalinului artificial
MX2022013665A (es) Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.
CA2905594A1 (en) Compositions for use in treating eye disorders using dipyridamole
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
NZ622403A (en) Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method
RU2017111579A (ru) Способы лечения и предотвращения заболеваний глаз, расстройств и патологических состояний меланином и аналогами, предшественниками и производными меланина
Gandorfer Pathology and Implications for Surgery
WO2002080915A3 (en) Composition for the treatment of night sight problems (halos, coma and glare) comprising aceclidine
MD3502F1 (ro) Metoda de tratament al cataractei traumatice
CY1121044T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια οφθαλμικων διαταραχων
RU2438629C1 (ru) Способ предупреждения развития хориоидальной неоваскуляризации после факоэмульсификации катаракты
RU2014106328A (ru) Фармацевтические композиции, содержащие 4-бром-n-(имидазолидин-2-илиден)-1н-бензимидазол-5-амин для лечения заболеваний сетчатки

Legal Events

Date Code Title Description
FG9Y Short term patent issued
MK4Y Short term patent expired